National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Understanding Cancer Series: Blood Stem Cell Transplants
< Back to Main
In English En español
    Posted: 09/01/2006    Reviewed: 09/01/2006
Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
PDF Version  View/Print PDF
PowerPoint Version  View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
The Cancer Genome Atlas Reports Brain Tumors Study

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Slide 24 : Cord Blood as a Source of Stem Cells previousnext

The human body's most primitive stem cells form in the fetal yolk sac and move to the fetal liver before entering the baby's bone marrow during the third trimester of pregnancy. When a baby is born, the placenta and umbilical cord still contain a rich supply of immature blood stem cells in the very process of migrating. These stem cells are capable of rebuilding all three types of blood cells in the body (red blood cells, immune cells, and platelets). First used in 1989 to help children with leukemia, cord-blood transplants have since proven themselves effective for adults too.

Cord Blood as a Source of Stem Cells

< Previous  |  Index  |  Next Slide >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov